Searched for
COST CUTTING PFIZER
Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cutsPfizer has reported impressive second-quarter earnings, driven by the success of Eliquis and newly acquired pharmaceutical products. The co...- Why Your Digital Investments Aren’t Creating ValueMany companies are pouring money into AI, analytics, and CRM platforms, yet struggle to translate those investments into measurable revenue...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Pfizer agrees to lower prescription drug costs for Medicaid in a deal with TrumpPfizer agreed to lower drug costs and invest $70 billion in U.S. manufacturing following a deal with the Trump administration. The drugmake...
- PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisitionPfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30, 2025. Presid...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer Q1 Results: Co lifts profit view on cost cuts, smaller drop in PaxlovidPfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cu...
- Market Movers: What drove investors to cement producers’ counters today?Cement sector was largely ignored by investors after the second wave buying rush because of the uneven demand environment as well as rising...
- Pfizer buying Hospira for about $15 billionThe deal is expected to add 10-12 cents per share to Pfizer's earnings in the first full-year after the deal closes.
- Pfizer boss enters lion's den of UK politics to sell AstraZeneca dealIn Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Pfizer to cut 1,100 R&D jobsPfizer Inc says it will lay off more than 1,000 employees at its Groton, Connecticut, research and development site as the drug giant cuts ...
- Wyeth to boost Pfizer's share in Indian marketPfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.
- Pfizer’s Q3 profit up on downsizing, higher salesPfizer, the world’s biggest drugmaker, said profit tripled because of higher sales of the pain pill Lyrica and lower costs from the 11,000 ...
- Bulk drug suppliers to come under FDA lensThe US Food & Drug Administration has been asked by a US senator to probe into outsourcing of pharma ingredients. Ranbaxy sell-off
- Pfizer considers outsourcing manufacturing to India, ChinaPfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities i...
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
- Pfizer to spend 300 mn dlr on R&D in KoreaPfizer Inc, the world's biggest drugmaker, will spend $300 million on research and development in South Korea by 2012, in what the governme...
- Pfizer sells fermentation plant in ChandigarhPfizer India is in the process of selling off its Chandigarh plant and has already received an advance of Rs 27.8 crore from the prospectiv...
Load More
